蒂尔泽帕提德诱导的注射部位反应
1Department of Medical Education Studies, International Research Center for Medical Education, Graduate School of Medicine, The University of Tokyo, Tokyo, JPN.
Cureus
|October 16, 2023
概括
一名患者在转换为一种类型的葡萄糖类-1 (GLP-1) 受体激活剂tirezepatide后,在注射部位出现了皮疹. 这种首次的案例突出了tirezepatide的存在.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 类似葡萄糖类-1受体激动剂 (GLP-1RA) 广泛用于治疗2型糖尿病和肥胖症.
- 注射部位反应是已知的与GLP-1RA治疗相关的潜在不良事件.
- 患者在没有不良事件的情况下使用皮下杜拉格卢提德的病史.
研究的目的:
- 报告首例与提尔泽帕提德相关的注射部位反应.
- 提高人们对与蒂尔泽帕提德使用相关的潜在不良事件的认识.
- 为了解GLP-1RA相关注射部位反应做出贡献.
主要方法:
- 一个70多岁的男性患者的病例报告.
- 详细观察从杜拉格卢提德转换为蒂尔泽帕提德后皮疹的发生情况.
- 在停止使用提尔泽帕蒂德后对反应的评估.
主要成果:
- 患者在开始服用tirzepatide后,在腹部下部出现局部皮疹.
- 皮疹在停止提尔泽帕提德治疗后消失.
- 之前没有发生过注射部位反应与杜拉格卢提德.
结论:
- 提尔泽帕提德可能会引起注射部位反应,即使在耐受其他GLP-1RA的患者中也是如此.
- 这一案例代表了首次记录的特泽帕提德诱导的注射部位反应.
- 临床医生应该警注射部位反应时,处方提尔泽帕提德.
相关概念视频
Allergic Drug Reactions
870
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
870
Insulin: Dosing Regimen and Adverse Effects
185
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
185
Drug Delivery: Parenteral Route
580
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
580


